Loading...
Targeted and novel therapy in advanced gastric cancer
The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth factor receptor 2 (HER2), mesenchymal–epithelial transi...
Saved in:
| Published in: | Exp Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6788003/ https://ncbi.nlm.nih.gov/pubmed/31632839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0149-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|